IBDEI0JB ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8689,1,3,0)
 ;;=3^Bone Mets
 ;;^UTILITY(U,$J,358.3,8689,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,8689,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,8690,0)
 ;;=C80.1^^39^401^171
 ;;^UTILITY(U,$J,358.3,8690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8690,1,3,0)
 ;;=3^Malig Neop,Primary,Unspec Site
 ;;^UTILITY(U,$J,358.3,8690,1,4,0)
 ;;=4^C80.1
 ;;^UTILITY(U,$J,358.3,8690,2)
 ;;=^5001389
 ;;^UTILITY(U,$J,358.3,8691,0)
 ;;=C80.0^^39^401^172
 ;;^UTILITY(U,$J,358.3,8691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8691,1,3,0)
 ;;=3^Malig Neop,Unspec Primary or Secondary
 ;;^UTILITY(U,$J,358.3,8691,1,4,0)
 ;;=4^C80.0
 ;;^UTILITY(U,$J,358.3,8691,2)
 ;;=^5001388
 ;;^UTILITY(U,$J,358.3,8692,0)
 ;;=E28.39^^39^401^96
 ;;^UTILITY(U,$J,358.3,8692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8692,1,3,0)
 ;;=3^Hypogonadism,Ovarian
 ;;^UTILITY(U,$J,358.3,8692,1,4,0)
 ;;=4^E28.39
 ;;^UTILITY(U,$J,358.3,8692,2)
 ;;=^5002752
 ;;^UTILITY(U,$J,358.3,8693,0)
 ;;=E29.1^^39^401^97
 ;;^UTILITY(U,$J,358.3,8693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8693,1,3,0)
 ;;=3^Hypogonadism,Testicular
 ;;^UTILITY(U,$J,358.3,8693,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,8693,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,8694,0)
 ;;=C96.20^^39^401^111
 ;;^UTILITY(U,$J,358.3,8694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8694,1,3,0)
 ;;=3^Malig Mast Cell Neoplasm,Unspec
 ;;^UTILITY(U,$J,358.3,8694,1,4,0)
 ;;=4^C96.20
 ;;^UTILITY(U,$J,358.3,8694,2)
 ;;=^5151293
 ;;^UTILITY(U,$J,358.3,8695,0)
 ;;=C96.22^^39^401^173
 ;;^UTILITY(U,$J,358.3,8695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8695,1,3,0)
 ;;=3^Mast Cell Sarcoma
 ;;^UTILITY(U,$J,358.3,8695,1,4,0)
 ;;=4^C96.22
 ;;^UTILITY(U,$J,358.3,8695,2)
 ;;=^5151295
 ;;^UTILITY(U,$J,358.3,8696,0)
 ;;=D64.9^^39^401^26
 ;;^UTILITY(U,$J,358.3,8696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8696,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,8696,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,8696,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,8697,0)
 ;;=D59.10^^39^401^32
 ;;^UTILITY(U,$J,358.3,8697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8697,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,8697,1,4,0)
 ;;=4^D59.10
 ;;^UTILITY(U,$J,358.3,8697,2)
 ;;=^5159101
 ;;^UTILITY(U,$J,358.3,8698,0)
 ;;=D59.11^^39^401^33
 ;;^UTILITY(U,$J,358.3,8698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8698,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Warm
 ;;^UTILITY(U,$J,358.3,8698,1,4,0)
 ;;=4^D59.11
 ;;^UTILITY(U,$J,358.3,8698,2)
 ;;=^5159102
 ;;^UTILITY(U,$J,358.3,8699,0)
 ;;=D59.12^^39^401^29
 ;;^UTILITY(U,$J,358.3,8699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8699,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Cold
 ;;^UTILITY(U,$J,358.3,8699,1,4,0)
 ;;=4^D59.12
 ;;^UTILITY(U,$J,358.3,8699,2)
 ;;=^5159103
 ;;^UTILITY(U,$J,358.3,8700,0)
 ;;=D59.13^^39^401^30
 ;;^UTILITY(U,$J,358.3,8700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8700,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Mixed Type
 ;;^UTILITY(U,$J,358.3,8700,1,4,0)
 ;;=4^D59.13
 ;;^UTILITY(U,$J,358.3,8700,2)
 ;;=^5159104
 ;;^UTILITY(U,$J,358.3,8701,0)
 ;;=D59.19^^39^401^31
 ;;^UTILITY(U,$J,358.3,8701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8701,1,3,0)
 ;;=3^Autoimmune Hemolytic Anemia,Other
 ;;^UTILITY(U,$J,358.3,8701,1,4,0)
 ;;=4^D59.19
 ;;^UTILITY(U,$J,358.3,8701,2)
 ;;=^5159105
 ;;^UTILITY(U,$J,358.3,8702,0)
 ;;=D57.20^^39^401^201
